Zoe Secrest, BA is a
Behavior Technician based in San Diego, California. Zoe Secrest is licensed to practice in California (license number RBT-25470091) and her current practice location is
3702 Ruffin Rd Ste 100, San Diego, California. She can be reached at her office (for appointments etc.) via phone at
(619) 297-4300.
NPI number for Zoe Secrest is 1205560885 and her current mailing address is 3702 Ruffin Rd Ste 100, San Diego, California. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1205560885.
Healthcare Provider's Profile
| Full Name | Zoe Secrest |
|---|
| Gender | Female |
|---|
| Speciality | Behavior Technician |
|---|
| Location | 3702 Ruffin Rd Ste 100, San Diego, California |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1205560885
- Provider Enumeration Date: 07/11/2022
- Last Update Date: 09/29/2025
Medical Identifiers
Medical identifiers for Zoe Secrest such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1205560885 | NPI | - | NPPES |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| 106S00000X | Behavior Technician | RBT-25470091 (California) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Zoe Secrest is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Zoe Secrest, BA 3702 Ruffin Rd Ste 100, San Diego, CA 92123-1893 Ph: (619) 297-4300 | Zoe Secrest, BA 3702 Ruffin Rd Ste 100, San Diego, CA 92123-1893 Ph: (619) 297-4300 |
Reviews and Comments